| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Reducing Canceled Labs Related to Specimen Integrity in the Neonatal Intensive Care Unit: A Quality Improvement Initiative
Phlebotomy Webinar
Expiration date: August 17, 2024
Reducing multiple redraws in the neonatal intensive care unit (NICU) is a constant goal for laboratory and nursing staff caring for neonatal patients. Frequent cancellation of labs following specimen collection due to issues with specimen integrity results in increased blood waste, painful procedures, and ultimately, a delayed treatment.
This presentation will walk learners through the quality improvement methodology and describe PDSA cycle interventions that were implemented in this unit, which successfully reduced the amount of canceled labs due to specimen integrity.
Paola Ramos, Ph.D.
Resident
Clinical Chemistry
Mayo Clinic, Rochester, Minnesota
Abby Streeton, APRN, CNS, M.S.N.
Clinical Nurse Specialist
Department of Nursing
Mayo Clinic, Rochester, Minnesota
Julie Lunde, M.S.N., R.N.
Nursing Education Specialist
Department of Nursing
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
This series is appropriate for phlebotomists, phlebotomy managers, phlebotomy educators, and other patient care staff involved in specimen collection.
The following types of credit are offered for this event:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of .5 P.A.C.E.® contact hour.
1. Watch the video.
2. Complete the posttest and evaluation that launches immediately following the video.
3. Generate and print your certificate(s).
Level of instruction for this program is basic.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: mcleducation@mayo.edu
